SCHEMBL5011082

SCHEMBL5011082

CN1C(=O)CC(c2ccc(N)c(N3CCC(C)(C)CC3)c2)CC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.38
MAPT P10636 3/20 0.38
HTT P42858 3/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 2/20 0.38
RECQL P46063 2/20 0.38
PTK2B Q14289 1/20 0.38
CYP19A1 P11511 1/20 0.38
LGMN Q99538 4/20 0.34
ALDH1A1 P00352 5/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PDE4A P27815 2/20 0.34
PDE4B Q07343 2/20 0.34
PDE4C Q08493 2/20 0.34
PDE4D Q08499 2/20 0.34
LMNA P02545 1/20 0.34
S100B P04271 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5011070 0.84 CDC7 (0.37) GAAMAPTHTTKDM4EALDH1A1
SCHEMBL5012417 0.83 GAA (0.38) GAAMAPTHTTMAPK1KDM4E
SCHEMBL1855898 0.75 BRD4 (0.43) GAAMAPTHTTKDM4ERECQL
SCHEMBL1858955 0.73 CSF1R (0.61)
SCHEMBL5006306 0.73 GAA (0.35) GAAMAPTHTTMAPK1KDM4E
SCHEMBL12381966 0.72 CSF1R (0.44) MAPK1
SCHEMBL5009212 0.71 GAA (0.50) GAAMAPTHTTMAPK1KDM4E
SCHEMBL14117230 0.71 CSF1R (0.40)
SCHEMBL5006260 0.71 GAA (0.49) GAAMAPTHTTMAPK1KDM4E
SCHEMBL1856162 0.70 CYP19A1 (0.64) CYP19A1KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296726-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2016-03-29 US disclosed
US-20150051196-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2015-02-19 US disclosed
US-8895584-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2014-11-25 US disclosed
US-20140243382-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2014-08-28 US disclosed
US-8759347-B2 Inhibitors of C-FMS kinase JANSSEN PHARMACEUTICA NV (BE) 2014-06-24 US disclosed
US-20130281475-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2013-10-24 US disclosed
US-8481564-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2013-07-09 US disclosed
US-20080275031-A1 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent ILLIG CARL R 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281475-A1 INHIBITORS OF C-FMS KINASE MUSK, FRK, FES GAA 3491/4885MAPT 75/4885HTT 1306/4885
US-20150051196-A1 INHIBITORS OF C-FMS KINASE MUSK, FRK, FES GAA 3491/4885MAPT 75/4885HTT 1306/4885
US-20140243382-A1 INHIBITORS OF C-FMS KINASE MUSK, FRK, FES GAA 3491/4885MAPT 75/4885HTT 1306/4885
US-20080275031-A1 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent MUSK, CHUK, CAMK4 GAA 3244/4885MAPT 128/4885HTT 1658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.